Fu Li
Impact in
-
- PARP inhibition in cancer therapy
- Cutaneous Melanoma Detection and Management
Papers in
-
- DNA Repair Mechanisms 2
-
- Biofuel production and bioconversion 2
- Co-authors
- Yao‐Wen Wu (3 shared papers)Qiang Li (1 shared paper)Yu Wu (1 shared paper)Bosheng Zhao (1 shared paper)Jianbin Zhang (1 shared paper)Kai Liu (1 shared paper)Anja Krüger (1 shared paper)Alexander Bürkle (1 shared paper)
- Journals
- American Journal of Cancer Research (2 papers)Fibers and Polymers (2 papers)Scientific Reports (1 paper)Chemical Communications (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Fu Li
37 papers receiving 421 citations
Peers
Comparison fields: 5 of 97
- Process Chemistry and Technology 13
- Oncology 111
- Physiology 11
- Molecular Biology 154
- Biomaterials 27
Countries citing papers authored by Fu Li
This map shows the geographic impact of Fu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Li more than expected).
Fields of papers citing papers by Fu Li
This network shows the impact of papers produced by Fu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Li. The network helps show where Fu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 100 | |
| 2 | 2020 | 52 | |
| 3 | 2014 | 45 | |
| 4 | 2019 | 31 | |
| 5 | 2021 | 24 | |
| 6 | Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and management. | 2020 | 20 |
| 7 | 2021 | 20 | |
| 8 | 2005 | 19 | |
| 9 | 2020 | 16 | |
| 10 | 2015 | 14 | |
| 11 | 2024 | 12 | |
| 12 | 2019 | 12 | |
| 13 | 2023 | 10 | |
| 14 | 2019 | 6 | |
| 15 | 2022 | 5 | |
| 16 | TSL-1502, a glucuronide prodrug of a poly (ADP-ribose) polymerase (PARP) inhibitor, exhibits potent anti-tumor activity in preclinical models. | 2021 | 5 |
| 17 | 2019 | 5 | |
| 18 | 2022 | 4 | |
| 19 | Selection of CBM drilling & completion methods by hierarchical analysis | 2011 | 2 |
| 20 | 高質量星形成領域G34.26+0.15への有機分子のミリ波観測【Powered by NICT】 | 2016 | 2 |
About Fu Li
Fu Li is a scholar working on Molecular Biology, Biomedical Engineering, Organic Chemistry, Mechanics of Materials and Epidemiology, having authored 39 papers that have together received 430 indexed citations. Recurring topics across this work include Click Chemistry and Applications (2 papers), DNA Repair Mechanisms (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Electrochemical Analysis and Applications (2 papers), PARP inhibition in cancer therapy (2 papers), Geoscience and Mining Technology (2 papers), Biofuel production and bioconversion (2 papers) and Geomechanics and Mining Engineering (1 paper). The work is most often cited by research in Process Chemistry and Technology (13 citations), Oncology (111 citations), Physiology (11 citations), Molecular Biology (154 citations) and Biomaterials (27 citations). Fu Li has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Yao‐Wen Wu, Qiang Li, Yu Wu, Bosheng Zhao, Jianbin Zhang, Kai Liu, Anja Krüger, Alexander Bürkle, Xingzhi Xu and Zhao‐Qi Wang. Their work appears in journals such as American Journal of Cancer Research, Fibers and Polymers, Scientific Reports, Chemical Communications and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.